Identification of Metronidazole – Drug Interactions at the Outpatient Setting in Alkharj

Main Article Content

Nehad J. Ahmad


Introduction: Metronidazole  is an antibacterial, antiprotozoal and amebicidal agent. It has a good activity against pathogenic anaerobic bacteria, low cost, minor adverse effects and a favorable pharmacodynamic and pharmacokinetic properties but still it interacts with many drugs.

Objective: This study aims to assess the interactions of metronidazole with other drugs at the outpatient setting in Alkharj.

Methodology: This is a retrospective study include revision of the electronic records in the outpatient setting in a public hospital in Alkharj in order to determine the incidence of interactions between metronidazole and other drugs in 2017.

Results: In the present study, the concurrent use of metronidazole with azithromycin, ciprofloxacin, domperidone, formoterol and olanzapine may result in increased risk of QT-interval prolongation and arrhythmias. The use of metronidazole with warfarin may result in increased risk of bleeding.

Conclusion: To dispense and prescribe it appropriately antimicrobial stewardship program should be implemented and checking practice should be implemented to avoid the occurrence of Drug - drug interactions.

Adverse reaction, antibiotics, drug interactions, metronidazole

Article Details

How to Cite
Ahmad, N. J. (2020). Identification of Metronidazole – Drug Interactions at the Outpatient Setting in Alkharj. Journal of Pharmaceutical Research International, 32(12), 76-80.
Original Research Article


Moore N, Biour M, Paux G, Loupi E, Begaud B, Boismare F, et al. Adverse drug reaction monitoring: Doing it the French way. Lancet. 1985;2(8463): 1056–8.

Bordet R, Gautier S, Le Louet H, Dupuis B, Caron J. Analysis of the direct cost of adverse drug reactions in hospitalised patients. Eur J Clin Pharmacol. 2001; 56(12):935–41.

Lee CE, Zembower TR, Fotis MA, Postelnick MJ, Greenberger PA, Peterson LR, et al. The incidence of antimicrobial allergies in hospitalized patients: implications regarding prescribing patterns and emerging bacterial resistance. Arch Intern Med. 2000;160(18):2819–22.

Gallelli L, Ferreri G, Colosimo M, Pirritano D, Flocco MA, Pelaia G, et al. Retrospective analysis of adverse drug reactions to bronchodilators observed in two pulmonary divisions of Catanzaro, Italy. Pharmacol Res. 2003; 47(6):493–9.

Gallelli L, Colosimo M, Pirritano D, Ferraro M, De Fazio S, Marigliano NM, et al. Retrospective evaluation of adverse drug reactions induced by nonsteroidal anti-inflammatory drugs. Clin Drug Investig. 2007;27(2):115–22.

Gallelli L, Colosimo M, Tolotta GA, Falcone D, Luberto L, Curto LS, et al. Prospective randomized double-blind trial of racecadotril compared with loperamide in elderly people with gastroenteritis living in nursing homes. Eur J Clin Pharmacol. 2010;66(2):137–44.

Gallelli L, Ferreri G, Colosimo M, Pirritano D, Guadagnino L, Pelaia G, et al. Adverse drug reactions to antibiotics observed in two pulmonology divisions of Catanzaro, Italy: A Six-Year Retrospective Study. Pharmacol Res. 2002;46(5):395–400.

Johnell K, Klarin I. The Relationship Between Number of Drugs and Potential Drug-Drug Interactions in the Elderly: A Study of Over 600,000 Elderly Patients From the Swedish Prescribed Drug Register. Drug Saf. 2007;30(10):911–8.

Franceschi A, Tuccori M, Bocci G, Vannozzi F, Di Paolo A, Barbara C, et al. Drug therapeutic failures in emergency department patients. A university hospital experience. Pharmacol Res. 2004;49:85-91.

Canu B, Fioravanti A, Orlandi P, Di Desidero T, Ali G, Fontanini G, et al. Irinotecan synergistically enhances the antiproliferative and proapoptotic effects of axitinib in vitro and improves its anticancer activity in vivo. Neoplasia. 2011;13(3):217–29.

Siniscalchi A, Gallelli L, Avenoso T, Squillace A, De Sarro G. Effects of carbamazepine/oxycodone coadministrtion in the treatment of trigeminal neuralgia. Ann Pharmacother. 2011;45(6):33.

Dukes GE. Over-the-counter antidiarrheal medications used for the self-treatment of acute nonspecific diarrhea. Am J Med. 1990;88(6):24-26.‏

Du Pont HL. Therapy for and Prevention of Traveler's Diarrhea. Clin Infect Dis. 2007; 45(1):78-84.‏

Yassin SF, Young-Fadok TM, Zein NN, Pardi DS. Clostridium difficile-associated diarrhea and colitis. Mayo Clin Proc. 2001; 76(7):725–730.

Samuelson J. Why Metronidazole Is Active Against Both Bacteria and Parasites. Antimicrob Agents Chemother. 1999;43(7): 1533-1541.‏

Löfmark S, Edlund C, Nord CE. Metronidazole Is Still the Drug of Choice for Treatment of Anaerobic Infections. Clin Infect Dis. 2010;50(1):16-23.‏

Karamanakos PN, Pappas P, Boumba VA, Thomas C, Malamas M, Vougiouklakis T et al. Pharmaceutical agents known to produce disulfiram-like reaction: effects on hepatic ethanol metabolism and brain monoamines. Int. J. Toxicol. 2007;26(5): 423-432.‏

Weathermon R, Crabb DW. Alcohol and Medication Interactions. Alcohol Res Health. 1999;23(1):40–54.

DRUGDEX® System. Intranet database, version 5.1. Thomson Micromedex; 2006.

Weibert RT, Lorentz SM, Townsend RJ, Cook CE, Klauber MR, Jagger PI. Effect of Erythromycin in Patients Receiving Long-Term Warfarin Therapy. Clin Pharm. 1989; 8(3):210–4.

Wells PS, Holbrook AM, Crowther NR, Hirsch J. Interactions of Warfarin With Drugs and Food. Ann Intern Med. 1994; 121(9):676–83.

Ament PW, Bertolino JG, Liszewski JL. Clinically Significant Drug Interactions. Am Fam Physician. 2000;61(6):1745‐ 1754.

Alonzo MM, Lewis TV, Miller JL. Disulfiram-like reaction with metronidazole: An unsuspected culprit. J Pediatr Pharmacol Ther. 2019;24(5):445-449.

Corsonello A, Abbatecola AM, Fusco S, Luciani F, Marino A, Catalano S, et al. The impact of drug interactions and polypharmacy on antimicrobial therapy in the elderly. Clin Microbiol Infect. 2015; 21(1):20-26.